Central Nervous System Depressants
"Central Nervous System Depressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).
Descriptor ID |
D002492
|
MeSH Number(s) |
D27.505.696.277 D27.505.954.427.210
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Depressants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Depressants".
This graph shows the total number of publications written about "Central Nervous System Depressants" by people in this website by year, and whether "Central Nervous System Depressants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2018 | 4 | 2 | 6 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Depressants" by people in Profiles.
-
Reply to: Letter to the Editor - N. Mitchell; Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease. J Neurol Sci. 2021 09 15; 428:117577.
-
Reply to: Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease. J Neurol Sci. 2021 09 15; 428:117578.
-
Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis. Subst Abus. 2021; 42(2):140-147.
-
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Oct 26; 21(1):882.
-
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19. Psychosomatics. 2020 Nov - Dec; 61(6):585-596.
-
COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report. Psychosomatics. 2020 Sep - Oct; 61(5):544-550.
-
Enteral versus intravenous approach for the sedation of critically ill patients: a randomized and controlled trial. Crit Care. 2019 Jan 07; 23(1):3.
-
Driving under the influence of opioids: What prescribers should know. J Opioid Manag. 2018 Nov/Dec; 14(6):415-427.
-
Efficacy of an ethyl alcohol gel in symptomatic disc herniation. Eur J Radiol. 2018 Dec; 109:101-107.
-
A Young Woman with Bradycardia and Hypotension. Ann Am Thorac Soc. 2018 09; 15(9):1092-1095.